Guoqing Hou

709 total citations
24 papers, 526 citations indexed

About

Guoqing Hou is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Guoqing Hou has authored 24 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Immunology. Recurrent topics in Guoqing Hou's work include Bone Metabolism and Diseases (5 papers), Bone health and treatments (3 papers) and Hedgehog Signaling Pathway Studies (2 papers). Guoqing Hou is often cited by papers focused on Bone Metabolism and Diseases (5 papers), Bone health and treatments (3 papers) and Hedgehog Signaling Pathway Studies (2 papers). Guoqing Hou collaborates with scholars based in China, United States and France. Guoqing Hou's co-authors include Xuan Cao, Xuedong Li, Chun Guo, Andong Liu, Xi Zhang, Yaosong Wu, Shi‐xin Du, Dongyang Huang, Hui Xu and Xudong Chen and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and The FASEB Journal.

In The Last Decade

Guoqing Hou

24 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guoqing Hou China 12 337 97 87 69 44 24 526
Xiangyang Leng China 14 309 0.9× 60 0.6× 65 0.7× 63 0.9× 51 1.2× 62 622
Xiangzhou Zeng China 15 385 1.1× 123 1.3× 146 1.7× 89 1.3× 68 1.5× 31 729
Dezhi Song China 15 482 1.4× 222 2.3× 97 1.1× 142 2.1× 61 1.4× 37 717
Rajalakshmy Ramalingam United States 9 288 0.9× 72 0.7× 162 1.9× 28 0.4× 40 0.9× 11 653
Jeong-Eun Kwon South Korea 12 305 0.9× 80 0.8× 155 1.8× 111 1.6× 43 1.0× 24 628
Chunling Li China 17 296 0.9× 125 1.3× 104 1.2× 103 1.5× 53 1.2× 39 695
Rui Han China 12 211 0.6× 53 0.5× 71 0.8× 47 0.7× 66 1.5× 52 676
Xiaoren Zhang United States 4 242 0.7× 135 1.4× 140 1.6× 154 2.2× 49 1.1× 4 523
Hangping Yao China 16 309 0.9× 92 0.9× 71 0.8× 48 0.7× 31 0.7× 33 578
Dongjie Fan China 14 296 0.9× 106 1.1× 81 0.9× 40 0.6× 34 0.8× 30 475

Countries citing papers authored by Guoqing Hou

Since Specialization
Citations

This map shows the geographic impact of Guoqing Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoqing Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoqing Hou more than expected).

Fields of papers citing papers by Guoqing Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoqing Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoqing Hou. The network helps show where Guoqing Hou may publish in the future.

Co-authorship network of co-authors of Guoqing Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Guoqing Hou. A scholar is included among the top collaborators of Guoqing Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoqing Hou. Guoqing Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Du, Jinxin, Guoqing Hou, Christophe Roblin, & Xue‐Xia Yang. (2025). An Active Learning-Based Adaptive Sampling Method for Efficient Far-Field Modeling of Flexible Antennas. IEEE Antennas and Wireless Propagation Letters. 24(7). 1779–1783. 1 indexed citations
3.
Hou, Guoqing, et al.. (2024). Corynoxine triggers cell death via activating PP2A and regulating AKT-mTOR/GSK3β axes in NSCLC. Biochemical Pharmacology. 222. 116110–116110. 7 indexed citations
4.
Xu, Hui, Ming Tan, Guoqing Hou, et al.. (2023). Blockade of DDR1/PYK2/ERK signaling suggesting SH2 superbinder as a novel autophagy inhibitor for pancreatic cancer. Cell Death and Disease. 14(12). 811–811. 9 indexed citations
5.
Grasberger, Helmut, Andrew T. Magis, Matthew P. Conomos, et al.. (2021). DUOX2 variants associate with preclinical disturbances in microbiota-immune homeostasis and increased inflammatory bowel disease risk. Journal of Clinical Investigation. 131(9). 42 indexed citations
6.
Xu, Lin, Xinge Zhang, Xin Yue, et al.. (2021). Depdc5 deficiency exacerbates alcohol-induced hepatic steatosis via suppression of PPARα pathway. Cell Death and Disease. 12(7). 710–710. 9 indexed citations
7.
Zhang, Xi, Hui Xu, Guoqing Hou, et al.. (2021). Src acts as the target of matrine to inhibit the proliferation of cancer cells by regulating phosphorylation signaling pathways. Cell Death and Disease. 12(10). 931–931. 28 indexed citations
8.
Deng, Jie, Xiangyu Ding, Xi Zhang, et al.. (2020). LKB1‐MARK2 signalling mediates lipopolysaccharide‐induced production of cytokines in mouse macrophages. Journal of Cellular and Molecular Medicine. 24(19). 11307–11317. 7 indexed citations
9.
Owyang, Stephanie Y., Min Zhang, Mohamad El‐Zaatari, et al.. (2020). Dendritic cell‐derived TGF‐β mediates the induction of mucosal regulatory T‐cell response to Helicobacter infection essential for maintenance of immune tolerance in mice. Helicobacter. 25(6). e12763–e12763. 18 indexed citations
10.
Zhang, Xi, Guoqing Hou, Andong Liu, et al.. (2019). Matrine inhibits the development and progression of ovarian cancer by repressing cancer associated phosphorylation signaling pathways. Cell Death and Disease. 10(10). 770–770. 49 indexed citations
11.
Deng, Jie, Andong Liu, Guoqing Hou, et al.. (2019). N-acetylcysteine decreases malignant characteristics of glioblastoma cells by inhibiting Notch2 signaling. Journal of Experimental & Clinical Cancer Research. 38(1). 2–2. 48 indexed citations
12.
Li, Xuedong, Bin Chen, Guoqing Hou, et al.. (2013). All-trans-retinoid acid (ATRA) may have inhibited chondrogenesis of primary hind limb bud mesenchymal cells by downregulating Pitx1 expression. Toxicology Letters. 224(2). 282–289. 3 indexed citations
13.
Hou, Guoqing, Chun Guo, Guohua Song, et al.. (2013). Lipopolysaccharide (LPS) promotes osteoclast differentiation and activation by enhancing the MAPK pathway and COX-2 expression in RAW264.7 cells. International Journal of Molecular Medicine. 32(2). 503–510. 98 indexed citations
14.
15.
Guo, Chun, Guoqing Hou, Xuedong Li, et al.. (2012). Quercetin Triggers Apoptosis of Lipopolysaccharide (LPS)-induced Osteoclasts and Inhibits Bone Resorption in RAW264.7 Cells. Cellular Physiology and Biochemistry. 30(1). 123–136. 41 indexed citations
16.
Yuan, Jianmin, et al.. (2011). Cisplatin induces apoptosis via upregulating Wrap53 in U-2OS osteosarcoma cells.. PubMed. 12(12). 3465–9. 14 indexed citations
17.
Li, Xuedong, Bo-Jui Chang, Bin Chen, et al.. (2010). <i>Panax notoginseng</i> Saponins Potentiate Osteogenesis of Bone Marrow Stromal Cells by Modulating Gap Junction Intercellular Communication Activities. Cellular Physiology and Biochemistry. 26(6). 1081–1092. 21 indexed citations
18.
Li, Xuedong, Jiansheng Wang, Bo-Jui Chang, et al.. (2010). Panax notoginseng saponins promotes proliferation and osteogenic differentiation of rat bone marrow stromal cells. Journal of Ethnopharmacology. 134(2). 268–274. 44 indexed citations
19.
Hou, Guoqing. (2001). Copper transportion of WD protein in hepatocytes from Wilson disease patientsin vitro. World Journal of Gastroenterology. 7(6). 846–846. 1 indexed citations
20.
Hou, Guoqing, et al.. (2000). Cu~(2+)-transporting in cultured hepatocytes of wilson disease patients. Journal of Sun Yat-sen University. 21(5). 330–333. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026